glp-1 hub podcast On episode 47 of the podcast, Dr. William Haas explains why oral Wegovy was more complex to create than injections., Comment "Episode 47" and I'll Auto-DM you a link to listen GLP-1 Hub - YouTube

In other words, manipulating a prescription outside of the intended use or extending it may cause safety concerns and consequences unaccounted for in research studies. If its unsafe to use any leftover medication in the pen after four weeks of injections, GLP-1 users may wonder whats the safest way to dispose of it

Type I interferon induction by Neisseria gonorrhoeae : dual requirement of cyclic GMP-AMP synthase and Toll-like receptor 4

If it has to do with better patient care, insurers and the pharmacy benefit managers will do a better job of explaining why are they doing these things, because at the end of the day, failing on a medicine is not a pleasant experience for the patient

Since GLP-1s are relatively new drugs, their long-term side effects are unknown

This article focuses on the basic mechanisms and actions of selected gut hormones/dual-agonists [glucagon-like-peptide (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon] and summarize the outcomes of trials evaluating these incretin agonists [2]